Chugai Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chugai Pharmaceutical Co Ltd with three other
companies in this sector in JAPAN :
Daiichi Sankyo Company Limited
sales of 929.72 billion Japanese Yen [US$8.64 billion]
of which 93%
was Prescription drugs),
Eisai Company Limited
(642.83 billion Japanese Yen [US$5.97 billion]
of which 88%
was Pharmaceutical Business), and
Mitsubishi Tanabe Pharma Corp
(424.77 billion Japanese Yen [US$3.95 billion]
of which 70%
was Domestic Ethical Drug).
Chugai Pharmaceutical Co Ltd reported sales of ¥686.18 billion (US$6.37 billion)
December of 2019.
increase of 18.4%
versus 2018, when the company's sales were ¥579.79 billion.
This was the third consecutive year of growth at Chugai Pharmaceutical Co Ltd.